Publish in this journal
Journal Information
Vol. 69. Issue 12.
Pages 1237 (December 2016)
Download PDF
More article options
Vol. 69. Issue 12.
Pages 1237 (December 2016)
Letter to the Editor
DOI: 10.1016/j.rec.2016.09.028
Full text access
Does Implementation of the Infarction Code Lead to Changes in the Treatment and Prognosis of Patients With Non-ST Elevation Acute Coronary Syndrome? Response
¿La implantación del código infarto implica cambios en el tratamiento y el pronóstico de los pacientes con síndrome coronario agudo sin elevación del ST? Respuesta
Alberto Cordero
Corresponding author

Corresponding author:
, Pilar Carrillo, Araceli Frutos, Ramón López-Palop
Departamento de Cardiología, Hospital Universitario de San Juan de Alicante, San Juan de Alicante, Alicante, Spain
Related content
Rev Esp Cardiol. 2016;69:1236-710.1016/j.rec.2016.08.014
Alfonso Jurado Román, Ignacio Sánchez Pérez, María T. López Lluva, Fernando Lozano Ruiz-Poveda
Article information
Full Text
Download PDF
Full Text
To the Editor,

We appreciate the compliments and comments from the team at the Catheterization Unit of the Hospital de Cuidad Real. We agree that the results observed in patients with non—ST-elevation acute coronary syndrome (NSTEACS) in our study1 are difficult to explain, given that the infarction code centers around ST-elevation acute coronary syndrome. Regarding their first question, the percentage of patients with NSTEACS classified as high risk increased from 3.9% to 12.6% (P=.01) after implementation of the infarction code. In this high-risk NSTEACS subgroup, the total revascularization rate increased from 62.5% to 87.5% (P=.04), but the rate of revascularization in the first 24hours did not increased (69.6% vs 62.5%; P=.89).

In response to their second question, in NSTEACS patients, the biggest change in drug treatment between the 2 periods was the use of the new antiplatelet agents, which increased from 1.4% to 32.6% (P<.01): ticagrelor, from 0% to 26.3%; and prasugrel, from 1.4% to 6.3% (P<.01 for both). This coincided with the dissemination of the antiplatelet therapy protocol in the infarction code, and is in line with the recommendations in clinical practice guidelines.2 The increased rate of revascularization, the increased use of new antiplatelet agents, and the general reorganization of the services involved in the infarction code could explain the benefits observed in NSTEACS patients.

With the exception of 1 privately-managed hospital that continued to use thrombolysis, primary angioplasty became practically the only reperfusion strategy in our area. Unless clinically contraindicated, all patients were transferred directly from the catheterization lab to the intensive care unit of their referring hospital. The organization of the infarction code in Alicante with 2 out of hours care areas means that the province's resources are concentrated in a rational and coherent way. This, combined with the endeavor of the professionals involved, has allowed primary angioplasty to enter into routine use, with the consequent benefits to the population.

A. Cordero, R. Lopez-Palop, P. Carrillo, A. Frutos, S. Miralles, C. Gunturiz, et al.
Cambios en el tratamiento y el pronóstico del síndrome coronario agudo con la implantación del código infarto en un hospital con unidad de hemodinámica.
Rev Esp Cardiol., 69 (2016), pp. 754-759
Grupo de Trabajo de la SEC/SECTCV para la guía de la ESC/EACTS 2014 sobre revascularización miocárdica, revisores expertos para la guía de la ESC/EACTS 2014 sobre revascularización miocárdica y Comité de Guías de la SEC. Comentarios a la guía de práctica clínica de la ESC/EACTS 2014 sobre revascularización miocárdica. Rev Esp Cardiol. 2015;68:92-7.
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?